Tyrosine Kinase Inhibitor-Induced Acute Myocarditis, Myositis, and Cardiogenic Shock

Methodist Debakey Cardiovasc J. 2018 Jul-Sep;14(3):e5-e6. doi: 10.14797/mdcj-14-3-e5.
No abstract available

Keywords: acute myocarditis; adverse events; sorafenib; tyrosine kinase inhibitors.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Antineoplastic Agents / adverse effects*
  • Biopsy
  • Cardiotoxicity
  • Coronary Angiography
  • Echocardiography
  • Female
  • Humans
  • Middle Aged
  • Myocarditis / chemically induced*
  • Myocarditis / diagnosis
  • Myocarditis / therapy
  • Myocardium / pathology
  • Myositis / chemically induced*
  • Myositis / diagnosis
  • Myositis / therapy
  • Protein Kinase Inhibitors / adverse effects*
  • Shock, Cardiogenic / chemically induced*
  • Shock, Cardiogenic / diagnosis
  • Shock, Cardiogenic / therapy
  • Sorafenib / adverse effects*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Sorafenib